Form 4: Director Shawn McCormick Receives RSU Grant at Inspire

Director Shawn McCormick was granted 3,562 restricted stock units in Inspire Medical Systems, Inc. as part of an equity incentive award.

Summary

• Director Shawn McCormick acquired 3,562 restricted stock units (RSUs) on April 30, 2026.
• Each RSU represents a contingent right to receive one share of common stock.
• The RSUs vest on the earlier of the first anniversary of the grant or immediately prior to a Change of Control, subject to continued service.
• Following this transaction, the reporting person holds 28,408 shares directly and 3,000 shares indirectly via a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon continued service with the issuer.

Future Outlook

The RSUs are scheduled to vest on April 30, 2027, or earlier in the event of a Change of Control.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests in the medical device sector.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices for mid-cap medical technology companies.
• Vesting schedules tied to annual anniversaries or change-of-control events are typical for executive and director compensation plans.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity grant.

Next Steps

• Vesting of the 3,562 RSUs on April 30, 2027.

Key Dates

Keywords

Inspire Medical Systems, INSP, Director, Insider Trading, Form 4, Equity Compensation